Akebia Therapeutics (AKBA) Restructuring Costs (2013 - 2024)

Akebia Therapeutics (AKBA) has 5 years of Restructuring Costs data on file, last reported at $58000.0 in Q1 2024.

• On a quarterly basis, Restructuring Costs fell 45.28% year-over-year to $58000.0 in Q1 2024; TTM through Dec 2024 was $58000.0, a 67.96% decrease from a year earlier, with the FY2024 full-year figure at $58000.0, down 67.96% from the prior year.
• Restructuring Costs for Q1 2024 stood at $58000.0, down from $169000.0 in the prior quarter.
• Over the last five years, Restructuring Costs for AKBA reached as high as $14.5 million in Q2 2022 and fell as low as -$94000.0 in Q2 2023.
• Historically, Restructuring Costs has averaged $2.3 million across 3 years, with a median of $169000.0 in 2023.
• On a YoY basis, Restructuring Costs climbed as much as 6.11% in 2023 and fell as far as 100.65% in 2023.
• Year by year, Restructuring Costs stood at $1.2 million in 2022, then plunged by 86.17% to $169000.0 in 2023, then sank by 65.68% to $58000.0 in 2024.
• Per Business Quant data, the three most recent Restructuring Costs figures were $58000.0 in Q1 2024, $169000.0 in Q3 2023, and -$94000.0 in Q2 2023.